HURA TuHURA Biosciences, Inc.: Company Short-Term Debts

Symbol and logo of brand TuHURA (HURA)

The following quotes for TuHURA Biosciences, Inc. (HURA) on GURU.Markets illustrate the debt dynamics, which currently stand at 0.00. TuHURA Biosciences, Inc. (HURA) specializes in developing advanced cancer vaccines using a tumor-deception method to activate the immune response. The firm's primary asset consists of unique patents for personalized therapy, although final capitalization depends on the results of the final clinical trials.

HURA tuhurabio.com Company Short-Term Loans and Borrowings (07/04/2022 - 11/01/2026)

HURA (TuHURA Biosciences Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price TuHURA|HURA - Consensus Target
- company stock capitalization data:
Market Capitalization TuHURA Biosciences, Inc.|HURA - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share TuHURA Biosciences|HURA - Accounting Value of Company|Market Cap to Net Assets Ratio tuhurabio.com|HURA - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital TuHURA Biosciences, Inc.|HURA - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio TuHURA|HURA - Company Aggregate Debts|Debt to Book Capitalization Ratio TuHURA Biosciences, Inc.|HURA - Company Long-Term Loans and Borrowings|Company Short-Term Debts TuHURA Biosciences|Quick Liquidity Indicator tuhurabio.com
- earnings and multiples data:
HURA - Profit After Payment of Taxes
Analysis of all company metrics:HURA - tuhurabio.com
Manufactured products of TuHURA Biosciences, Inc.

Experienced investors filter blue-chip assets through liquidity and debt sustainability analysis. This metric measures obligations maturing within one year, determining the business's sensitivity to changes in borrowing costs. The current value of 0.00 reflects the financial burden associated with upgrading cryogenic equipment and maintaining laboratories. A reduction in this indicator minimizes the risk of capital drawdowns. Short-term debt load dynamics confirm the liquidity management strategy of TuHURA Biosciences (HURA).

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Current Liabilities CTOR (Citius Oncology, Inc.)|Amount of Current Liabilities TARA|Fate Therapeutics - Company Current Liabilities|Company Short-Term Debts Aadi Bioscience, Inc. WHWK|TScan - Company Short-Term Debts|Company Short-Term Loans and Borrowings CSBR (Champions Oncology)|XBIT (xbiotech.com) - Company Current Liabilities|CEL-SCI (CVM) - Company Short-Term Debts|Company Short-Term Debt OS Therapies|RADX: Company Short-Term Loans and Borrowings|Company Short-Term Debts ARTV|Company Short-Term Debts adlainortye.com (ANL)|Veru Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings TPST|Xilio - Company Short-Term Debts|RENB: Company Short-Term Debt|MURA: Company Short-Term Debts|KAPA - Short-Term Debt Volume|Company Short-Term Debt OnKure Therapeutics, Inc.|Short-Term Debt CytoMed GDTC|Company Short-Term Debt Curis, Inc. (CRIS)|Short-Term Debt Volume apollomicsinc.com|Company Short-Term Debts THAR (Tharimmune Corp)|ADVB - Company Current Liabilities|Genprex, Inc. - Company Short-Term Debts|Short-Term Debt Volume Calidi Biotherapeutics CLDI|SBFM: Company Short-Term Debts|Short-Term Debt Xenetic Biosciences, Inc. (XBIO)|Company Short-Term Debt Salarius|Company Short-Term Indebtedness PPBT (Kitov Pharma)|Company Short-Term Debts AONC|Company Current Liabilities beigene.com BGNE|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Elevation Oncology Inc. (ELEV) - Short-Term Debt|ICAD - Company Short-Term Debt|Short-Term Debt Volume Ikena Oncology, Inc. IKNA|NTBL (Notable Labs, Ltd.) - Company Current Liabilities|Viracta Therapeutics, Inc. - Company Short-Term Loans and Borrowings|MOR (MorphoSys) - Company Short-Term Debts|NAYA Biosciences Inc (NAYA) - Short-Term Debt Volume|Company Short-Term Debt Ascentage Pharma Group Ltd (AAPGV)